Ascites surgery: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Ascites}} {{CMG}} {{AE}} {{MUT}} ==Overview== ==Surgery== ===Liver transplantation=== {{main|liver transplantation}} Ascites that is refractory to medical thera...")
 
No edit summary
 
(4 intermediate revisions by 2 users not shown)
Line 2: Line 2:
{{Ascites}}
{{Ascites}}


{{CMG}} {{AE}} {{MUT}}
{{CMG}} {{AE}} {{EG}}


==Overview==
==Overview==
[[Surgery]] is the mainstay of treatment for [[refractory]] ascites. [[Refractory]] ascites is defined as ascites that can not be mobilized or the early recurrence of which can not be satisfactorily prevented by medical therapy. Large volume [[paracentesis]] is the choice treatment for patients with tense ascites. [[Transjugular intrahepatic portosystemic shunt|Transjugular intrahepatic portosystemic shunt (TIPS)]] would be indicated when there is frequent (> 3 times per month) need for large volume [[paracentesis]] to manage ascites. [[Liver transplantation]] is indicated for [[refractory]] ascites treatment in patients that can not be underwent [[TIPS]].


==Surgery==
==Surgery==
* [[Surgery]] is the mainstay of treatment for [[refractory]] ascites. [[Refractory]] ascites is defined as ‘''ascites that can not be mobilized or the early recurrence of which can not be satisfactorily prevented by medical therapy''<nowiki/>'.<ref name="pmid">{{cite journal |vauthors=Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F, Angeli P, Porayko M, Moreau R, Garcia-Tsao G, Jimenez W, Planas R, Arroyo V |title=The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club |journal=Hepatology |volume=38 |issue=1 |pages=258–66 |year=2003 |pmid= |doi=10.1053/jhep.2003.50315 |url=}}</ref>
* [[Refractory]] ascites is contributed with very poor [[prognosis]], 50% of them would die within 6 months. Using [[Beta-blocker therapy|beta-blocker agents]] (for preventing [[esophageal varices]] in [[cirrhosis]]) can cause poorer [[prognosis]] in ascitis.<ref name="pmid25398769">{{cite journal |vauthors=Krag A, Madsen BS |title=To block, or not to block in advanced cirrhosis and ascites: that is the question |journal=Gut |volume=64 |issue=7 |pages=1015–7 |year=2015 |pmid=25398769 |doi=10.1136/gutjnl-2014-308424 |url=}}</ref>
* The process of administering various surgical treatments is as following:<ref name="pmid21455322">{{cite journal| author=Biecker E| title=Diagnosis and therapy of ascites in liver cirrhosis. | journal=World J Gastroenterol | year= 2011 | volume= 17 | issue= 10 | pages= 1237-48 | pmid=21455322 | doi=10.3748/wjg.v17.i10.1237 | pmc=3068258 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21455322  }}</ref>
{{family tree/start}}
{{family tree| | | | | | A01 | | | | | | | | | |A01='''Refractory Ascites''' }}
{{family tree| | | | | | |!| | | | | | | | | | |}}
{{family tree| | | | | | B01 | | | | | | | | | |B01='''''Large volume [[paracentesis]]'''''}}
{{family tree| | | | | | |!| | | | | | | | | | |}}
{{family tree| | | | | | C01 | | | | | | | | | |C01=Salt restriction and [[diuretics]]}}
{{family tree| | | |,|-|-|^|-|-|-|.| | | | | | |}}
{{family tree| | | B01 | | | | | B02 | | | | | |B01=Controlled|B02=Not controlled}}
{{family tree| | | |!| | | |,|-|-|^|-|-|.| | | |}}
{{family tree| | | C01 | | C02 | | | | C03 | | |C01=Salt restriction and [[diuretics]]|C02=[[TIPS]] possible|C03=[[TIPS]] not possible}}
{{family tree| | | | | | | |!| | | | | |!| | | |}}
{{family tree| | | | | | | D01 | | | | D02 | | |D01='''''[[TIPS]]'''''|D02=Repeated '''''Large volume [[paracentesis]]'''''}}
{{family tree| | | | | | | | | | | | | |!| | | |}}
{{family tree| | | | | | | | | | | | | E01 | | |E01='''''[[Liver transplant]]'''''}}
{{family tree/end}}
=== Large volume paracentesis ===
* Large volume [[paracentesis]] is the choice treatment for patients with tense ascites.
* The rate of [[complications]] is very low in this procedure.<ref name="pmid15740535">{{cite journal |vauthors=Pache I, Bilodeau M |title=Severe haemorrhage following abdominal paracentesis for ascites in patients with liver disease |journal=Aliment. Pharmacol. Ther. |volume=21 |issue=5 |pages=525–9 |year=2005 |pmid=15740535 |doi=10.1111/j.1365-2036.2005.02387.x |url=}}</ref>
* The most common [[complication]] following [[paracentesis]] is [[paracentesis]]-induced [[circulatory]] dysfunction (PICD). The condition is due to systemic [[vasoconstriction]] in response to massive central fluid loss, which can lead to [[hepatorenal syndrome]] in 20% of patients.<ref name="pmid3360270">{{cite journal |vauthors=Ginès P, Titó L, Arroyo V, Planas R, Panés J, Viver J, Torres M, Humbert P, Rimola A, Llach J |title=Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis |journal=Gastroenterology |volume=94 |issue=6 |pages=1493–502 |year=1988 |pmid=3360270 |doi= |url=}}</ref>
* [[Paracentesis]] of less than 5 L fluid can be done without need to [[colloid]] [[infusion]] for preventing PICD.<ref name="pmid9068457">{{cite journal |vauthors=Peltekian KM, Wong F, Liu PP, Logan AG, Sherman M, Blendis LM |title=Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites |journal=Am. J. Gastroenterol. |volume=92 |issue=3 |pages=394–9 |year=1997 |pmid=9068457 |doi= |url=}}</ref>
=== Transjugular Intrahepatic Portosystemic Shunt (TIPS) ===
* [[Transjugular intrahepatic portosystemic shunt|Transjugular intrahepatic portosystemic shunt (TIPS)]] would be indicated when there is frequent (> 3 times per month) need for large volume [[paracentesis]] to manage ascites.
* [[TIPS]] is side-to-side [[anastomosis]] between high pressure [[portal vein]] and low pressure [[hepatic vein]], in order to decline the [[portal]] congestion.<ref name="pmid9588766">{{cite journal |vauthors=Rössle M, Siegerstetter V, Huber M, Ochs A |title=The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art |journal=Liver |volume=18 |issue=2 |pages=73–89 |year=1998 |pmid=9588766 |doi= |url=}}</ref>
* [[TIPS]] is more effective than [[paracentesis]] in mobilizing ascites fluid. However, it is more prevalent in [[TIPS]] patients to develop [[hepatic encephalopathy]].<ref name="pmid17054221">{{cite journal |author=Saab S, Nieto JM, Lewis SK, Runyon BA |title=TIPS versus paracentesis for cirrhotic patients with refractory ascites |journal=Cochrane database of systematic reviews (Online) |volume= |issue=4 |pages=CD004889 |year=2006 |pmid=17054221 |doi=10.1002/14651858.CD004889.pub2}}</ref>
===Liver transplantation===
===Liver transplantation===
{{main|liver transplantation}}
* [[Liver transplantation]] is indicated for [[refractory]] ascites treatment in patients that can not be underwent [[TIPS]].<ref name="pmid21455322" />
Ascites that is refractory to medical therapy is considered an indication for [[liver transplantation]]. In the United States, the MELD score ([http://www.unos.org/resources/meldPeldCalculator.asp online calculator])<ref name="pmid2682175">{{cite journal |author=Cosby RL, Yee B, Schrier RW |title=New classification with prognostic value in cirrhotic patients |journal=Mineral and electrolyte metabolism |volume=15 |issue=5 |pages=261-6 |year=1989 |pmid=2682175 |doi=}}</ref> is used to prioritize patients for transplantation.
 
===Shunting===
In a minority of the patient with advanced cirrhosis that have recurrent ascites, shunts may be used. Typical shunts used are [[portacaval shunt]], [[peritoneovenous shunt]], and the [[transjugular intrahepatic portosystemic shunt]] (TIPS). However, none of these shunts has been shown to extend life expectancy, and are considered to be bridges to [[liver transplantation]].
A [[meta-analysis]] of [[randomized controlled trials]] by the international [[Cochrane Collaboration]] concluded that "TIPS was more effective at removing ascites as compared with paracentesis...however, TIPS patients develop hepatic encephalopathy significantly more often"
<ref name="pmid17054221">{{cite journal |author=Saab S, Nieto JM, Lewis SK, Runyon BA |title=TIPS versus paracentesis for cirrhotic patients with refractory ascites |journal=Cochrane database of systematic reviews (Online) |volume= |issue=4 |pages=CD004889 |year=2006 |pmid=17054221 |doi=10.1002/14651858.CD004889.pub2}}</ref>


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}


[[Category: Medicine]]
[[Category: Up-To-Date]]
[[Category: Gastroenterology]]
[[Category: Hepatology]]
[[Category: Emergency medicine]]
{{WH}}
{{WH}}
{{WS}}
{{WS}}

Latest revision as of 14:58, 26 January 2018

Ascites Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Ascites from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ascites surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ascites surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ascites surgery

CDC on Ascites surgery

Ascites surgery in the news

Blogs on Ascites surgery

Directions to Hospitals Treating Ascites

Risk calculators and risk factors for Ascites surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Eiman Ghaffarpasand, M.D. [2]

Overview

Surgery is the mainstay of treatment for refractory ascites. Refractory ascites is defined as ascites that can not be mobilized or the early recurrence of which can not be satisfactorily prevented by medical therapy. Large volume paracentesis is the choice treatment for patients with tense ascites. Transjugular intrahepatic portosystemic shunt (TIPS) would be indicated when there is frequent (> 3 times per month) need for large volume paracentesis to manage ascites. Liver transplantation is indicated for refractory ascites treatment in patients that can not be underwent TIPS.

Surgery

 
 
 
 
 
Refractory Ascites
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Large volume paracentesis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Salt restriction and diuretics
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Controlled
 
 
 
 
Not controlled
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Salt restriction and diuretics
 
TIPS possible
 
 
 
TIPS not possible
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TIPS
 
 
 
Repeated Large volume paracentesis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liver transplant
 
 

Large volume paracentesis

Transjugular Intrahepatic Portosystemic Shunt (TIPS)

Liver transplantation

References

  1. Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F, Angeli P, Porayko M, Moreau R, Garcia-Tsao G, Jimenez W, Planas R, Arroyo V (2003). "The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club". Hepatology. 38 (1): 258–66. doi:10.1053/jhep.2003.50315.
  2. Krag A, Madsen BS (2015). "To block, or not to block in advanced cirrhosis and ascites: that is the question". Gut. 64 (7): 1015–7. doi:10.1136/gutjnl-2014-308424. PMID 25398769.
  3. 3.0 3.1 Biecker E (2011). "Diagnosis and therapy of ascites in liver cirrhosis". World J Gastroenterol. 17 (10): 1237–48. doi:10.3748/wjg.v17.i10.1237. PMC 3068258. PMID 21455322.
  4. Pache I, Bilodeau M (2005). "Severe haemorrhage following abdominal paracentesis for ascites in patients with liver disease". Aliment. Pharmacol. Ther. 21 (5): 525–9. doi:10.1111/j.1365-2036.2005.02387.x. PMID 15740535.
  5. Ginès P, Titó L, Arroyo V, Planas R, Panés J, Viver J, Torres M, Humbert P, Rimola A, Llach J (1988). "Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis". Gastroenterology. 94 (6): 1493–502. PMID 3360270.
  6. Peltekian KM, Wong F, Liu PP, Logan AG, Sherman M, Blendis LM (1997). "Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites". Am. J. Gastroenterol. 92 (3): 394–9. PMID 9068457.
  7. Rössle M, Siegerstetter V, Huber M, Ochs A (1998). "The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art". Liver. 18 (2): 73–89. PMID 9588766.
  8. Saab S, Nieto JM, Lewis SK, Runyon BA (2006). "TIPS versus paracentesis for cirrhotic patients with refractory ascites". Cochrane database of systematic reviews (Online) (4): CD004889. doi:10.1002/14651858.CD004889.pub2. PMID 17054221.

Template:WH Template:WS